Skip to content
Bamboo Works
Search
Register / Sign in
MSCI China | MSCI China Small-Cap | Hang Seng Index | Hang Seng China Enterprise
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Premium Content
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Premium Content
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

Covid-19

Clover Biopharmaceuticals Ltd. faces a potentially damaging fight

Dispute over Covid vaccines casts doubt on Clover Bio recovery

The Chinese biopharma firm faces a potentially damaging fight over a $224 million upfront payment it received in an ill-fated deal to supply Covid vaccines Key Takeaways: The Gavi international…
April 3, 2025
2197.HK

KE results show green shoots of recovery after real-estate winter

China’s top property broker insulated itself against a market downturn by expanding into home furnishings and rentals, helping it deliver a quarterly profit Key Takeaways: KE Holdings recorded a modest…
March 24, 2023
2423.HK BEKE.US

FAST NEWS: Ascletis Pharma’s Monkeypox Drug Gets IND Approval

The latest: Ascletis Pharma Inc. (1672.HK) announced on Thursday that the China National Medical Products Administration (NMPA) has approved an Investigational New Drug (IND) application for its oral viral polymerase…
January 27, 2023

Riding Covid Vaccine Highs, CanSino Plans Swiss Listing

The first vaccine stock to be listed in the both Mainland China and Hong Kong will issue global depositary receipts (GDRs) in SwitzerlandKey Takeaways:After successful listings in Shanghai and Hong…
January 17, 2023

FAST NEWS: Topsports’ Quarterly Sales Decline, But Shares Still Jump

The latest: Topsports International Holdings Ltd. (6110.HK), a major distributor for Nike and Adidas in China, said on Wednesday combined sales for its retail and wholesale operations registered a high-teens decline year-on-year in…
December 22, 2022

FAST NEWS: Ascletis Covid, Monkeypox Virus Inhibitor Gets U.S. Patent

The latest: Ascletis Pharma Inc. (1672.HK) said on Monday the U.S. Patent and Trademark Office (USPTO) has granted it a patent for its oral viral polymerase inhibitor ASC10 and its…
December 20, 2022

FAST NEWS: SSY Group Signs Preliminary Deal to Make Fever Medication

The latest: SSY Group Ltd. (2005.HK) said on Sunday it signed a letter of intent with a well-known Chinese pharmaceutical company to produce 1 billion to 2.5 billion ibuprofen sustained-release…
December 19, 2022
Load more

Recent Articles

Clover Biopharmaceuticals Ltd. faces a potentially damaging fight
April 3, 2025

Dispute over Covid vaccines casts doubt on Clover Bio recovery

2197.HK
March 24, 2023

KE results show green shoots of recovery after real-estate winter

2423.HK BEKE.US
January 27, 2023

FAST NEWS: Ascletis Pharma’s Monkeypox Drug Gets IND Approval

January 17, 2023

Riding Covid Vaccine Highs, CanSino Plans Swiss Listing

December 22, 2022

FAST NEWS: Topsports’ Quarterly Sales Decline, But Shares Still Jump

December 20, 2022

FAST NEWS: Ascletis Covid, Monkeypox Virus Inhibitor Gets U.S. Patent

December 19, 2022

FAST NEWS: SSY Group Signs Preliminary Deal to Make Fever Medication

RELATED ARTICLES

  1. NaaS exits infrastructure business
    November 25, 2024
    NaaS drives into third quarter with first-ever quarterly non-IFRS profit
    NAAS.US
  2. November 27, 2024
    Hesai zooms ahead in third quarter, setting stage for milestone year
    HSAI.US
  3. January 20, 2025
    NEWS WRAP: Profit plunges at JinkoSolar’s main China-listed unit
    JKS.US 688223.SHG
  4. January 24, 2025
    Lopal steers back towards profitability after tough two years
    2465.HK 603906.SHG
  5. November 15, 2024
    BRIEF: China Gold International swings to profit in third quarter
    2099.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Premium Content
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2024 Bamboo Works. All rights reserved.